Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Astronomers detect rare 'free floating' exoplanet 10,000 light-years from Earth - 2Civilian toll mounts in Iran as war presses on
- 3Vote In favor of Your Favored Kind Of Tea
- 4China's 1st reusable rocket explodes in dramatic fireball during landing after reaching orbit on debut flight
- 5NASA's Apollo 8 moonshot saved 1968. Could Artemis 2 do the same in 2026?
- Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
- In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
- Can a mammogram help identify heart disease?
- Deaths reported in Lebanon as Israel and Hezbollah exchange attacks
- Iranian president warns of retaliation against Gulf states
- Virtual reality opens doors for older people to build closer connections in real life
- Norovirus is spreading earlier again this year, wastewater data shows
- EU top diplomat Kallas arrives in Kiev to commemorate Bucha massacre
- Which game do you cherish observing live? Vote!
